Acasti Pharma Inc.
ACST

$34.17 M
Marketcap
$3.37
Share price
Country
$0.13
Change (1 day)
$3.60
Year High
$1.98
Year Low
Categories

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

marketcap

Revenue of Acasti Pharma Inc. (ACST)

Revenue in 2023 (TTM): $

According to Acasti Pharma Inc.'s latest financial reports the company's current revenue (TTM) is $. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history of Acasti Pharma Inc.

Annual Revenue

Year Revenue Gross Profit Ebitda Income Before Tax Net Income
2023 $ $-11,000 $-11,301,000 $-14,630,000 $-12,853,000
2022 $ $-52,155,000 $15.85 M $-51,971,000 $-42,429,000
2021 $ $-15,589,000 $-19,989,000 $-10,467,000 $-9,819,000
2020 $196 K $120 K $-12,306,781 $-19,678,000 $-19,678,000
2019 $ $-2,320,000 $-21,828,000 $-25,513,000 $-25,760,000
2018 $ $-2,333,000 $-30,988,616 $-38,620,431 $-43,861,594
2017 $ $ $-14,007,945 $-16,651,567 $-16,942,722
2016 $ $ $ $ $
2015 $27.79 K $-32,294 $-5,271,488 $-4,661,416 $-4,661,416
2014 $216.29 K $28.39 K $-7,970,323 $-1,322,541 $-1,322,541
2013 $450.16 K $187.86 K $-8,840,829 $-10,435,936 $-10,435,936
2012 $707.4 K $310.45 K $-6,122,063 $-6,732,464 $-6,732,464
2011 $127.11 K $122.01 K $-5,857,884 $-6,538,661 $-6,538,661
2010 $29.04 K $29.04 K $-2,424,116 $ $-2,426,846
2009 $ $ $-1,529,677 $-1,527,334 $-1,508,303